Neurobiological Technologies Provides Company Update to J.M. Dutton Research Team - Webcast Available to all Interested Investors - RICHMOND, Calif., May 12 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) announced today that Paul E. Freiman, President and Chief Executive Officer of NTI, will present a corporate overview and answer questions posed by analysts with J.M. Dutton & Associates in a webcast presentation that will be available starting on May 12, 2004 at 1:00 p.m. (EDT). All interested parties are invited to listen to the webcast. The webcast can be accessed at http://www.jmdutton.com/research/ntii/index_road_show.html and will be archived and accessible at the same website for 90 days. Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 24 analysts, primarily CFAs, have wide industry coverage experience. Dutton & Associates provides bias-free, continuing analyst coverage of over 70 enrolled companies, and its institutional-quality research, estimates, and recommendations are carried in all the major databases serving institutions and online investors. About Neurobiological Technologies, Inc. NTI is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The company's strategy is to in-license and develop early-and later-stage drug candidates that target major medical needs and which can be rapidly commercialized. The company's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy and seeks partnerships with pharmaceutical and biotechnology companies to complete development and marketing of its product candidates. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730, or Roger Pondel, or Rob Whetstone, both of PondelWilkinson Inc., +1-323-866-6050, for Neurobiological Technologies, Inc. Web site: http://www.ntii.com/ http://www.jmdutton.com/research/ntii/index_road_show.html

Copyright

Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Neurobiological Charts.
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Neurobiological Charts.